Chao Melissa, Menon Carlo, Elgendi Mohamed
Department of Medicine, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.
Biomedical and Mobile Health Technology Laboratory, Department of Health Sciences and Technology, Zurich, Switzerland.
Front Med (Lausanne). 2022 Jun 14;9:865134. doi: 10.3389/fmed.2022.865134. eCollection 2022.
As the coronavirus disease 2019 (COVID-19) continues to devastate health systems worldwide, there is particular concern over the health and safety of one high-risk group, pregnant women, due to their altered immune systems. Since health workers regularly rely on symptoms to inform clinical treatment, it became critical to maintain a ranked list of COVID-19 symptoms specific to pregnant women. This systematic review investigated the prevalence of common COVID-19 symptoms in pregnant women and compared the ranked list of symptoms to articles of various sizes. Articles were included if they discussed pregnant women diagnosed with COVID-19 using polymerase chain reaction testing, and women present symptoms of COVID-19 and were published between December 1, 2019, and December 1, 2021; while articles were excluded if they did not report on pregnant women with COVID-19 displaying symptoms of COVID-19. Articles were identified on OVID MedLine and Embase in January of 2022. The risk of bias and quality appraisal was assessed using a nine-item modified Scottish Intercollegiate Guidelines Network checklist for case-control studies. The search results included 78 articles that described 41,513 pregnant women with 42 unique COVID-19 symptoms. When ranked, the most common symptoms were found to be cough (10,843 cases, 16.02%), fever (7,653 cases, 11.31%), myalgia (6,505 cases, 9.61%), headache (5,264 cases, 7.78%), and dyspnea (5,184 cases, 7.66%). When compared to other articles in the literature with sample sizes of = 23,434, = 8,207, and = 651, the ranking largely aligned with those in other articles with large sample sizes and did not align with the results of articles with small sample sizes. The symptom ranking may be used to inform testing for COVID-19 in the clinic. Research is rapidly evolving with the ongoing nature of the pandemic, challenging the generalizability of the results.
随着2019冠状病毒病(COVID-19)继续肆虐全球卫生系统,由于免疫系统发生变化,一个高风险群体——孕妇的健康和安全尤其令人担忧。由于医护人员通常依靠症状来指导临床治疗,因此维持一份针对孕妇的COVID-19症状排名清单变得至关重要。这项系统评价调查了孕妇中常见COVID-19症状的患病率,并将症状排名清单与各种规模的文章进行了比较。如果文章讨论了使用聚合酶链反应检测诊断为COVID-19的孕妇,且这些孕妇出现了COVID-19症状,并于2019年12月1日至2021年12月1日期间发表,则纳入这些文章;如果文章未报告患有COVID-19且出现COVID-19症状的孕妇,则将其排除。2022年1月在OVID MedLine和Embase上检索到了相关文章。使用一份针对病例对照研究的九项改良苏格兰校际指南网络清单评估偏倚风险和质量评估。检索结果包括78篇文章,描述了41513名孕妇出现的42种独特的COVID-19症状。排名时,发现最常见的症状是咳嗽(10843例,16.02%)、发热(7653例,11.31%)、肌痛(6505例,9.61%)、头痛(5264例,7.78%)和呼吸困难(5184例,7.66%)。与文献中样本量分别为 = 23434、 = 8207和 = 651 的其他文章相比,该排名在很大程度上与其他大样本量文章的排名一致,而与小样本量文章的结果不一致。症状排名可用于指导临床中COVID-19的检测。随着疫情的持续发展,研究也在迅速演变,这对结果的普遍性提出了挑战。